Replicate Bioscience
Pre-clinicalReplicate Bioscience is pioneering novel self-replicating RNA (srRNA) technology to enable more treatment opportunities for more people.
Founded
2019
Focus
RNA & Gene Therapy
About
Replicate Bioscience is pioneering novel self-replicating RNA (srRNA) technology to enable more treatment opportunities for more people.
Funding History
2Total raised: $80M
Series A$40MATPJun 15, 2022
Seed$40MATPJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile